Pyogenic Liver Abscess
Main Article Content
Abstract
They predominate between the fifth and sixth decade of life, due to the higher incidence of neoplasms and complex biliary diseases, with higher incidence in countries with temperate climate. Most are secondary to biliary or gastrointestinal tract infection. It is often preceded by symptoms that vary from days to two to three weeks, with fever in 90% of patients, followed by hepatomegaly, attack of the general condition, weight loss, anorexia and vomiting and finally hepatodynia. Mortality rates vary in various series from 5 to 10% in North America and Europe to 3 to 30% worldwide. The difference probably lies in the pathology responsible for the condition. Mortality has been shown to be higher in older patients with multiple comorbidities, including cirrhosis, renal failure, sepsis and cancer. Patients treated with aspiration or percutaneous drainage have half the mortality of those treated with antibiotic therapy alone.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Longworth S, Han J. Pyogenic Liver Abscess. Clin Liver Dis .2015; 6(2). doi: 10.1002/cld.487.
II. Kaplan GG, Gregson DB, Laupland KB. Population-based study of the epidemiology of and the risk factors for pyogenic liver abscess. Clin Gastroenterol Hepatol .2004; 2(11): p.1032-1038. doi: 10.1016/S1542- 3565(04)00459-8.
III. Meddings L, Myers RP, Hubbard J, et al. A population-based study of pyogenic liver abscesses in the United States: Incidence, mortality and temporal trends. Am J Gastroenterol .2009; 105(1): p.117-124.
doi: 10.1038/ajg.2009.614.
IV. Mavilia MG, Molina M,Wu GY. The Evolving Nature of Hepatic Abscess: A Review. J Clin Transl Hepatol .2016; 4(2).
doi: 10.14218/jcth.2016.00004.
V. Rahimian J, Wilson T, Oram V, Holzman RS. Pyogenic liver abscess: recent trends in etiology and mortality. Clinical Infectious Diseases .2004; 39(11): p.1654-16599. doi: 10.1086/425616
VI. Kurland JE, Brann OS. Pyogenic and amebic liver abscesses. Curr Gastroenterol Rep .2004; 6(4): p.273-279. doi: 10.1007/s11894-004-0078-2.
VII. Webb GJ, Chapman TP, Cadman PJ, Gorard DA. Pyogenic liver abscess. Frontline Gastroenterol .2013; 5(1): p.60-67. doi: 10.1136/flgastro-2013- 100371.
VIII. Fousekis FS, Theopistos VI, Katsanos KH, Tsianos EV, Christodoulou DK. Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review. Gastroenterology Res .2018; 11(2): p.83-94.
doi: 10.14740/gr990w.
IX. Mukthinuthalapati VVPK, Attar BM, Parra-Rodriguez L, Cabrera NL, Araujo T, Gandhi S. Risk Factors, Management, and Outcomes of Pyogenic Liver Abscess in a US Safety Net Hospital. Dig Dis Sci .2019; 65(5): p.1529-1538. doi: 10.1007/s10620-019-05851-9.
X. Fazili T, Sharngoe C, Endy T, Kiska D, Javaid W, Polhemus M. Klebsiella pneumoniae Liver Abscess: An Emerging Disease. Am J Med Sci .2016; 351(3): p.297-304.
doi: 10.1016/j.amjms.2015.12.018.
XI. Bächler P, Baladron MJ, Menias C, et al. Multimodality Imaging of Liver Infections: Differential Diagnosis and Potential Pitfalls. RadioGraphics. 2016; 36(4): p.1001-1023.
doi: 10.1148/rg.2016150196.
XII. Barosa R, Pinto J, Caldeira A, Pereira E. Modern role of clinical ultrasound in liver abscess and echinococcosis. J Med Ultrason .2016; 44(3): p.239- 245. doi: 10.1007/s10396-016-0765-2.
XIII. Chernyak V, Horowitz JM, Kamel IR, et al. ACR Appropriateness Criteria® Liver Lesion-Initial Characterization. J Am Coll Radiol .2020; 17(11): p.S429-S446.
doi: 10.1016/j.jacr.2020.09.005.
XIV. Petri A, Höhn J, Hódi Z, Wolfárd A, Balogh A. Pyogenic liver abscess -- 20 years' experience. Comparison of results of treatment in two periods. Langenbecks Arch Surg .2002; 387(1): p.27-31. doi: 10.1007/s00423-002- 0279-9.
XV. Lipsett PA, Huang CJ, Lillemoe KD, Cameron JL, Pitt HA. Fungal hepatic abscesses: Characterization and management. J Gastrointestinal Surg.1997; 1(1): p.78-84. pmid: 9834333.
XVI. Mazuski JE, Tessier JM, May AK, et al. The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection. Surg Infect (Larchmt) .2017; 18(1): p.1-76.
doi: 10.1089/sur.2016.261.
XVII. Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis .2010; 50(2): p.133-164.
doi: 10.1086/649554
XVIII. Charles HW. Abscess drainage. Semin Intervent Radiol .2012; 29(4): p.325- 336. doi: 10.1055/s-0032-1330068.
XIX. Patel IJ, Davidson JC, Nikolic B, et al. Addendum of Newer Anticoagulants to the SIR Consensus Guideline. J Vasc Interv Radiol .2013; 24(5): p.641- 645.
doi: 10.1016/j.jvir.2012.12.007.
XX. Cai Y-L, Xiong X-Z, Lu J, et al. Percutaneous needle aspiration versus catheter drainage in the management of liver abscess: a systematic review and meta-analysis. HPB (Oxford) .2015; 17(3): p.195-201. doi: 10.1111/hpb.12332.
XXI. Romano G, Agrusa A, Frazzetta G, et al. Laparoscopic drainage of the liver abscess: case report and literature review. G Chir .2013; 34(5-6): p.180- 182.
doi: 10.11138/gchir/2013.34.5.180.
XXII. Yang DM, Kim HN, Kang JH, Seo TS, Park CH, Kim HS. Complications of pyogenic hepatic abscess: computed tomography and clinical features. J Comput Assist Tomogr .2004; 28(3): p.311-317. pmid: 15100533.
XXIII. Chung SD, Tsai MC, Lin HC. Increased risk of pneumonia following pyogenic liver abscess: a nationwide population-based study. Int J Infect Dis.2013; 17(8): p.e634-637.
doi: 10.1016/j.ijid.2013.01.016.
XXIV. Agabegi SS, Agabegi ED. Step-Up To Medicine. Baltimore, MD, USA: Wolters Kluwer Health; 2015.
XXV. 25. Davis J, Malcolm McDonald M. Pyogenic liver abscess. In: Post TW, ed. UpToDate.Waltham,MA:UpToDate.https://www.uptodate.com/contents/pyogenic-liver-abscess.